BioSight
Companies
C4 Therapeutics, Inc. logo

CCCC

NASDAQWATERTOWN, MA
C4 Therapeutics, Inc.

C4 Therapeutics develops drug candidates using its TORPEDO platform technology to treat various disease indications through targeted protein degradation. The company is in the preclinical and clinical trial stages of development, working to advance multiple product candidates toward regulatory approval while managing risks related to funding, clinical trial outcomes, and competition in the biotech industry.

Price history not yet available for CCCC.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar